EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glucagon-like peptide-1 receptor agonists across anti-inflammation

Daohong Chen

Molecular Aspects of Medicine · 2026-06 · 109 · 101474

DOI: 10.1016/j.mam.2026.101474 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Aspects of Medicine, 2026-06. Verfasst von Daohong Chen. Beteiligte Einrichtung: Research Institute, Changshan Biochemical Pharmaceutical, 71 Menglong Street, Zhengding New District, Shijiazhuang, Hebei, 050800, China. Electronic …. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Anti-Inflammatory Agents, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) can ignite the downstream signal transduction in various tissues/organs due to the receptor expression across cell types, thus playing multifaceted biological roles in and beyond anti-diabetes. Besides metabolic benefits, anti-inflammatory pathology is emerging as an attractive mode to inspire expanding therapeutic utilities of GLP-1RAs, through the synergistic cellular/molecular mechanisms of modulating meta-inflammation or immuno-metabolism. Thus this article presents a trending profile of representative inflammation-mediated diseases which are likely to be alleviated upon pharmacological augmentation of GLP-1 signaling, including cardiovascular disorders, metabolic associated steatohepatitis, neurodegenerative illness, arthritis and inflammatory bowel disease. Insights herein tend to systemically highlight an ongoing translation from the comprehensive GLP-1 effects on multiple organs into greater clinical application of GLP-1RA medication for inflammatory indications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsAnti-Inflammatory AgentsInflammationHumansAnimalsSignal TransductionGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1

Stichwörter der Autor:innen

GLP-1RAMeta-inflammationTranslational pharmacology

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsAnti-Inflammatory AgentsGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1

Autor:innen und Institutionen

  • Research Institute, Changshan Biochemical Pharmaceutical, 71 Menglong Street, Zhengding New District, Shijiazhuang, Hebei, 050800, China. Electronic address: daohong@hotmail.com.

Zitieren

APA

Chen, D. (2026). Glucagon-like peptide-1 receptor agonists across anti-inflammation. Molecular Aspects of Medicine, 109, 101474. https://doi.org/10.1016/j.mam.2026.101474

Vancouver

Chen D. Glucagon-like peptide-1 receptor agonists across anti-inflammation. Molecular Aspects of Medicine. 2026;109:101474. doi:10.1016/j.mam.2026.101474

BibTeX
@article{Chen2026,
  author = {Chen, Daohong},
  title = {Glucagon-like peptide-1 receptor agonists across anti-inflammation},
  journal = {Molecular Aspects of Medicine},
  year = {2026},
  volume = {109},
  pages = {101474},
  doi = {10.1016/j.mam.2026.101474}
}
Kostenlos starten →